Heat Biologics shares spiked 77% as the biopharma company reported positive interim data from the Phase 2 trial of its lung cancer treatment. …
It has been three weeks since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the …
Shares of nanocap Heat Biologics (HTBX) have almost quadrupled over the last 10 days. While the overall market has been gripped by turmoil …
With the number of global coronavirus infections now exceeding 93,000, Wall Street observers aren’t sure that monetary policy will be enough to limit …
With its stock gaining over 250% in just a few days, Heat Biologics (NASDAQ:HTBX) is cashing out at the top. On Thursday, the …
After pricing an equity offering that will dilute current investors but help shore up its balance sheet, shares in Heat Biologics Inc (NASDAQ:HTBX) are …
Mobileye NV (NYSE:MBLY) shares are soaring by 29% on Monday morning following the announcement that computer-chip giant Intel is acquiring Mobileye for …
Heat Biologics Inc (NASDAQ:HTBX) shares fell over 65% this month, after the firm’s Phase II data read-out from its HS-410 bladder cancer trial …
The biotech-verse is in full upheaval mode as Heat Biologics Inc (NASDAQ:HTBX) shares nosedive following disheartening Phase II results in bladder cancer and …
Today, Heat Biologics Inc (NASDAQ:HTBX) presented randomized Phase II data from the HS-410 bladder cancer study. The primary endpoint of the study, one …
